The invention concerns 2-aminomethyl-benzo[a]quinolizidine derivatives, corresponding to general formula (I) in which: R1 represents either a hydrogen atom or a branched, linear or cyclic C1-C4 alkyl group, a branched, linear or cyclic C1-C4 hydroxy or alkoxy group, or a halogen atom such as F or Cl; R2 represents a hydrogen atom or a C1-C6 alkyl group; R3 represents a hydrogen atom or can constitute a unit (C=X)-NR4R5 and in that case constitutes a urea or thiourea with X = oxygen or sulphur; R4 and R5 can independently be a hydrogen atom or a linear, branched, cyclic C1-C8 alkyl group, an aryl, aralkyl, aroyl group, said aryl groups capable of being substituted as well; R4 and R5 can be bound by a carbon chain optionally incorporating a heteroatom.
AMINOMETHYL-BENZO A QUINOLIZIDINE DERIVATIVES, PREPARATION AND THERAPEUTIC APPLICATIONS FOR NEURODEGENRATIVE DISEASES